Caribou Biosciences, Inc. CRBU
Super Investor & Insider
1
Fondi che lo detengono
#1319
Rank consenso
1.4%
% dei portafogli
$1.2M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | 0.01% | — | 652,542 | $1.2M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Caribou Biosciences Inc. is at the forefront of biotechnology, specializing in genome-editing technologies. This company primarily focuses on developing novel therapeutic solutions by leveraging CRISPR-derived gene-editing platforms. With its innovative approach, Caribou aims to address critical challenges in disease t…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees97
TickerCRBU
Statistics
Market Cap$162.9M
Revenue (TTM)$11.2M
Net Income-$148.1M
Net Margin-1327.4%
EPS$-1.59
P/E-1.07
P/S14.70
P/B1.58
EV/EBITDA-0.65
ROE-83.5%
Dividend Yield—
Price$1.68
Data: Twelve Data · Revenue = mcap / P/S